{"id":29326,"date":"2026-08-10T09:31:27","date_gmt":"2026-08-10T13:31:27","guid":{"rendered":"https:\/\/zerohorabrasil.com\/ultimas-noticias\/consulta-publica-avalia-inclusao-no-sus-de-remedio-para-hipertensao\/"},"modified":"2026-08-10T09:31:27","modified_gmt":"2026-08-10T13:31:27","slug":"consulta-publica-avalia-inclusao-no-sus-de-remedio-para-hipertensao","status":"publish","type":"post","link":"https:\/\/zerohorabrasil.com\/saude-e-bem-estar\/consulta-publica-avalia-inclusao-no-sus-de-remedio-para-hipertensao\/","title":{"rendered":"Consulta p\u00fablica avalia inclus\u00e3o no SUS de rem\u00e9dio para hipertens\u00e3o"},"content":{"rendered":"<\/p>\n<p>\n                    <img decoding=\"async\" src=\"https:\/\/cdn.jsdelivr.net\/gh\/sergiosdlima\/assets-ebc@1.0.0\/abr\/assets\/images\/logo-agenciabrasil.svg\" alt=\"Logo Ag\u00eancia Brasil\"><\/p>\n<p>A Comiss\u00e3o Nacional de Incorpora\u00e7\u00e3o de Tecnologias no Sistema \u00danico de Sa\u00fade (Conitec) abriu consulta p\u00fablica para avaliar a inclus\u00e3o do medicamento sotatercepte na rede p\u00fablica, para\u00a0tratamento de pacientes adultos com hipertens\u00e3o arterial pulmonar (HAP). <strong>As contribui\u00e7\u00f5es, da sociedade civil e da comunidade m\u00e9dica,\u00a0podem ser enviadas at\u00e9 o pr\u00f3ximo dia 17.<\/strong><img decoding=\"async\" src=\"https:\/\/agenciabrasil.ebc.com.br\/ebc.png?id=1699208&#038;o=rss\"><img decoding=\"async\" src=\"https:\/\/agenciabrasil.ebc.com.br\/ebc.gif?id=1699208&#038;o=rss\"><\/p>\n<p>De acordo com a Conitec, a solicita\u00e7\u00e3o de incorpora\u00e7\u00e3o foi feita pelo pr\u00f3prio fabricante do medicamento para o tratamento de adultos com HAP em classes funcionais III ou IV, conforme crit\u00e9rios da Organiza\u00e7\u00e3o Mundial da Sa\u00fade (OMS), com risco de mortalidade intermedi\u00e1rio a alto, em uso de terapia dupla, quando houver intoler\u00e2ncia \u00e0s prostaciclinas, ou em uso de terapia tripla, associado ao tratamento j\u00e1 em uso.<\/p>\n<\/p>\n<h3>Not\u00edcias relacionadas:<\/h3>\n<ul>\n<li>Cirurgias pl\u00e1sticas de mama no SUS crescem mais de 50% em dez anos.<\/li>\n<li>Medicamento reduz em at\u00e9 85% interna\u00e7\u00f5es no SUS por fibrose c\u00edstica.<\/li>\n<\/ul>\n<p><strong>Ainda segundo a comiss\u00e3o, o medicamento age no mecanismo de crescimento das c\u00e9lulas dos vasos sangu\u00edneos. Na HAP, essa via pode estar desregulada e contribuir para o estreitamento dos vasos dos pulm\u00f5es.<\/strong><\/p>\n<h2>A doen\u00e7a<\/h2>\n<p><strong>A hipertens\u00e3o arterial pulmonar \u00e9 uma doen\u00e7a rara, cr\u00f4nica, progressiva e grave. Isso significa que \u00e9 uma condi\u00e7\u00e3o pouco frequente na popula\u00e7\u00e3o, de longa dura\u00e7\u00e3o e que pode piorar com o tempo, comprometendo a capacidade da pessoa de realizar atividades do dia a dia.<\/strong><\/p>\n<p>Na HAP, ocorre aumento da press\u00e3o nos vasos sangu\u00edneos que levam o sangue do cora\u00e7\u00e3o para os pulm\u00f5es. Com isso, o lado direito do cora\u00e7\u00e3o precisa fazer mais esfor\u00e7o para bombear o sangue.<\/p>\n<p>Ao longo do tempo, esse esfor\u00e7o pode sobrecarregar o cora\u00e7\u00e3o e causar sintomas como falta de ar, cansa\u00e7o, tontura, dor no peito, desmaios e dificuldade para realizar atividades habituais. <strong>Em casos mais graves, a doen\u00e7a pode evoluir para insufici\u00eancia card\u00edaca, levar ao funcionamento insuficiente do cora\u00e7\u00e3o e morte.<\/strong><\/p>\n","protected":false},"excerpt":{"rendered":"<p>A Comiss\u00e3o Nacional de Incorpora\u00e7\u00e3o de Tecnologias no Sistema \u00danico de Sa\u00fade (Conitec) abriu consulta p\u00fablica para avaliar a inclus\u00e3o do medicamento sotatercepte na rede p\u00fablica, para\u00a0tratamento de pacientes adultos com hipertens\u00e3o arterial pulmonar (HAP). As contribui\u00e7\u00f5es, da sociedade civil e da comunidade m\u00e9dica,\u00a0podem ser enviadas at\u00e9 o pr\u00f3ximo dia 17. De acordo com a [&hellip;]<\/p>\n","protected":false},"author":340,"featured_media":29327,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"rop_custom_images_group":[],"rop_custom_messages_group":[],"rop_publish_now":"initial","rop_publish_now_accounts":{"facebook_9136735276363284_1546287478841159":""},"rop_publish_now_history":[],"rop_publish_now_status":"pending","_jetpack_newsletter_access":"","_jetpack_dont_email_post_to_subs":false,"_jetpack_newsletter_tier_id":0,"_jetpack_memberships_contains_paywalled_content":false,"_jetpack_feature_clip_id":0,"_jetpack_memberships_contains_paid_content":false,"footnotes":"","jetpack_post_was_ever_published":false},"categories":[11],"tags":[],"class_list":["post-29326","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-saude-e-bem-estar"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v28.4 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Consulta p\u00fablica avalia inclus\u00e3o no SUS de rem\u00e9dio para hipertens\u00e3o -<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/zerohorabrasil.com\/ultimas-noticias\/consulta-publica-avalia-inclusao-no-sus-de-remedio-para-hipertensao\/\" \/>\n<meta property=\"og:locale\" content=\"pt_BR\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Consulta p\u00fablica avalia inclus\u00e3o no SUS de rem\u00e9dio para hipertens\u00e3o -\" \/>\n<meta property=\"og:description\" content=\"A Comiss\u00e3o Nacional de Incorpora\u00e7\u00e3o de Tecnologias no Sistema \u00danico de Sa\u00fade (Conitec) abriu consulta p\u00fablica para avaliar a inclus\u00e3o do medicamento sotatercepte na rede p\u00fablica, para\u00a0tratamento de pacientes adultos com hipertens\u00e3o arterial pulmonar (HAP). As contribui\u00e7\u00f5es, da sociedade civil e da comunidade m\u00e9dica,\u00a0podem ser enviadas at\u00e9 o pr\u00f3ximo dia 17. De acordo com a [&hellip;]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/zerohorabrasil.com\/ultimas-noticias\/consulta-publica-avalia-inclusao-no-sus-de-remedio-para-hipertensao\/\" \/>\n<meta property=\"article:published_time\" content=\"2026-08-10T13:31:27+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/cdn.jsdelivr.net\/gh\/sergiosdlima\/assets-ebc@1.0.0\/abr\/assets\/images\/logo-agenciabrasil.svg\" \/>\n<meta name=\"author\" content=\"Paula Laboissiere - Reporter da Agencia Brasil\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Escrito por\" \/>\n\t<meta name=\"twitter:data1\" content=\"Paula Laboissiere - Reporter da Agencia Brasil\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. tempo de leitura\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutos\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/zerohorabrasil.com\\\/ultimas-noticias\\\/consulta-publica-avalia-inclusao-no-sus-de-remedio-para-hipertensao\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/zerohorabrasil.com\\\/ultimas-noticias\\\/consulta-publica-avalia-inclusao-no-sus-de-remedio-para-hipertensao\\\/\"},\"author\":{\"name\":\"Paula Laboissiere - Reporter da Agencia Brasil\",\"@id\":\"https:\\\/\\\/zerohorabrasil.com\\\/#\\\/schema\\\/person\\\/babb8a03cd770e7624473e9dc0bcc401\"},\"headline\":\"Consulta p\u00fablica avalia inclus\u00e3o no SUS de rem\u00e9dio para hipertens\u00e3o\",\"datePublished\":\"2026-08-10T13:31:27+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/zerohorabrasil.com\\\/ultimas-noticias\\\/consulta-publica-avalia-inclusao-no-sus-de-remedio-para-hipertensao\\\/\"},\"wordCount\":359,\"commentCount\":0,\"image\":{\"@id\":\"https:\\\/\\\/zerohorabrasil.com\\\/ultimas-noticias\\\/consulta-publica-avalia-inclusao-no-sus-de-remedio-para-hipertensao\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/zerohorabrasil.com\\\/wp-content\\\/uploads\\\/2026\\\/08\\\/29326-consulta-publica-avalia-inclusao-no-sus-de-remedio-para-hipertensao.jpg\",\"articleSection\":[\"Sa\u00fade e Bem-Estar\"],\"inLanguage\":\"pt-BR\",\"potentialAction\":[{\"@type\":\"CommentAction\",\"name\":\"Comment\",\"target\":[\"https:\\\/\\\/zerohorabrasil.com\\\/ultimas-noticias\\\/consulta-publica-avalia-inclusao-no-sus-de-remedio-para-hipertensao\\\/#respond\"]}]},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/zerohorabrasil.com\\\/ultimas-noticias\\\/consulta-publica-avalia-inclusao-no-sus-de-remedio-para-hipertensao\\\/\",\"url\":\"https:\\\/\\\/zerohorabrasil.com\\\/ultimas-noticias\\\/consulta-publica-avalia-inclusao-no-sus-de-remedio-para-hipertensao\\\/\",\"name\":\"Consulta p\u00fablica avalia inclus\u00e3o no SUS de rem\u00e9dio para hipertens\u00e3o -\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/zerohorabrasil.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/zerohorabrasil.com\\\/ultimas-noticias\\\/consulta-publica-avalia-inclusao-no-sus-de-remedio-para-hipertensao\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/zerohorabrasil.com\\\/ultimas-noticias\\\/consulta-publica-avalia-inclusao-no-sus-de-remedio-para-hipertensao\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/zerohorabrasil.com\\\/wp-content\\\/uploads\\\/2026\\\/08\\\/29326-consulta-publica-avalia-inclusao-no-sus-de-remedio-para-hipertensao.jpg\",\"datePublished\":\"2026-08-10T13:31:27+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/zerohorabrasil.com\\\/#\\\/schema\\\/person\\\/babb8a03cd770e7624473e9dc0bcc401\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/zerohorabrasil.com\\\/ultimas-noticias\\\/consulta-publica-avalia-inclusao-no-sus-de-remedio-para-hipertensao\\\/#breadcrumb\"},\"inLanguage\":\"pt-BR\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/zerohorabrasil.com\\\/ultimas-noticias\\\/consulta-publica-avalia-inclusao-no-sus-de-remedio-para-hipertensao\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"pt-BR\",\"@id\":\"https:\\\/\\\/zerohorabrasil.com\\\/ultimas-noticias\\\/consulta-publica-avalia-inclusao-no-sus-de-remedio-para-hipertensao\\\/#primaryimage\",\"url\":\"https:\\\/\\\/zerohorabrasil.com\\\/wp-content\\\/uploads\\\/2026\\\/08\\\/29326-consulta-publica-avalia-inclusao-no-sus-de-remedio-para-hipertensao.jpg\",\"contentUrl\":\"https:\\\/\\\/zerohorabrasil.com\\\/wp-content\\\/uploads\\\/2026\\\/08\\\/29326-consulta-publica-avalia-inclusao-no-sus-de-remedio-para-hipertensao.jpg\",\"width\":1600,\"height\":800,\"caption\":\"Consulta p\u00fablica avalia inclus\u00e3o no SUS de rem\u00e9dio para hipertens\u00e3o\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/zerohorabrasil.com\\\/ultimas-noticias\\\/consulta-publica-avalia-inclusao-no-sus-de-remedio-para-hipertensao\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"In\u00edcio\",\"item\":\"https:\\\/\\\/zerohorabrasil.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Consulta p\u00fablica avalia inclus\u00e3o no SUS de rem\u00e9dio para hipertens\u00e3o\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/zerohorabrasil.com\\\/#website\",\"url\":\"https:\\\/\\\/zerohorabrasil.com\\\/\",\"name\":\"\",\"description\":\"Zh Brasil\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/zerohorabrasil.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"pt-BR\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/zerohorabrasil.com\\\/#\\\/schema\\\/person\\\/babb8a03cd770e7624473e9dc0bcc401\",\"name\":\"Paula Laboissiere - Reporter da Agencia Brasil\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"pt-BR\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/be7b690da94cabc2c5adfe3cc496f57cd07f0fce2816487d69375f431356fe96?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/be7b690da94cabc2c5adfe3cc496f57cd07f0fce2816487d69375f431356fe96?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/be7b690da94cabc2c5adfe3cc496f57cd07f0fce2816487d69375f431356fe96?s=96&d=mm&r=g\",\"caption\":\"Paula Laboissiere - Reporter da Agencia Brasil\"},\"url\":\"https:\\\/\\\/zerohorabrasil.com\\\/author\\\/paula-laboissiere-reporter-da-agencia-brasil-2\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Consulta p\u00fablica avalia inclus\u00e3o no SUS de rem\u00e9dio para hipertens\u00e3o -","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/zerohorabrasil.com\/ultimas-noticias\/consulta-publica-avalia-inclusao-no-sus-de-remedio-para-hipertensao\/","og_locale":"pt_BR","og_type":"article","og_title":"Consulta p\u00fablica avalia inclus\u00e3o no SUS de rem\u00e9dio para hipertens\u00e3o -","og_description":"A Comiss\u00e3o Nacional de Incorpora\u00e7\u00e3o de Tecnologias no Sistema \u00danico de Sa\u00fade (Conitec) abriu consulta p\u00fablica para avaliar a inclus\u00e3o do medicamento sotatercepte na rede p\u00fablica, para\u00a0tratamento de pacientes adultos com hipertens\u00e3o arterial pulmonar (HAP). As contribui\u00e7\u00f5es, da sociedade civil e da comunidade m\u00e9dica,\u00a0podem ser enviadas at\u00e9 o pr\u00f3ximo dia 17. De acordo com a [&hellip;]","og_url":"https:\/\/zerohorabrasil.com\/ultimas-noticias\/consulta-publica-avalia-inclusao-no-sus-de-remedio-para-hipertensao\/","article_published_time":"2026-08-10T13:31:27+00:00","og_image":[{"url":"https:\/\/cdn.jsdelivr.net\/gh\/sergiosdlima\/assets-ebc@1.0.0\/abr\/assets\/images\/logo-agenciabrasil.svg","type":"","width":"","height":""}],"author":"Paula Laboissiere - Reporter da Agencia Brasil","twitter_card":"summary_large_image","twitter_misc":{"Escrito por":"Paula Laboissiere - Reporter da Agencia Brasil","Est. tempo de leitura":"2 minutos"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/zerohorabrasil.com\/ultimas-noticias\/consulta-publica-avalia-inclusao-no-sus-de-remedio-para-hipertensao\/#article","isPartOf":{"@id":"https:\/\/zerohorabrasil.com\/ultimas-noticias\/consulta-publica-avalia-inclusao-no-sus-de-remedio-para-hipertensao\/"},"author":{"name":"Paula Laboissiere - Reporter da Agencia Brasil","@id":"https:\/\/zerohorabrasil.com\/#\/schema\/person\/babb8a03cd770e7624473e9dc0bcc401"},"headline":"Consulta p\u00fablica avalia inclus\u00e3o no SUS de rem\u00e9dio para hipertens\u00e3o","datePublished":"2026-08-10T13:31:27+00:00","mainEntityOfPage":{"@id":"https:\/\/zerohorabrasil.com\/ultimas-noticias\/consulta-publica-avalia-inclusao-no-sus-de-remedio-para-hipertensao\/"},"wordCount":359,"commentCount":0,"image":{"@id":"https:\/\/zerohorabrasil.com\/ultimas-noticias\/consulta-publica-avalia-inclusao-no-sus-de-remedio-para-hipertensao\/#primaryimage"},"thumbnailUrl":"https:\/\/zerohorabrasil.com\/wp-content\/uploads\/2026\/08\/29326-consulta-publica-avalia-inclusao-no-sus-de-remedio-para-hipertensao.jpg","articleSection":["Sa\u00fade e Bem-Estar"],"inLanguage":"pt-BR","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/zerohorabrasil.com\/ultimas-noticias\/consulta-publica-avalia-inclusao-no-sus-de-remedio-para-hipertensao\/#respond"]}]},{"@type":"WebPage","@id":"https:\/\/zerohorabrasil.com\/ultimas-noticias\/consulta-publica-avalia-inclusao-no-sus-de-remedio-para-hipertensao\/","url":"https:\/\/zerohorabrasil.com\/ultimas-noticias\/consulta-publica-avalia-inclusao-no-sus-de-remedio-para-hipertensao\/","name":"Consulta p\u00fablica avalia inclus\u00e3o no SUS de rem\u00e9dio para hipertens\u00e3o -","isPartOf":{"@id":"https:\/\/zerohorabrasil.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/zerohorabrasil.com\/ultimas-noticias\/consulta-publica-avalia-inclusao-no-sus-de-remedio-para-hipertensao\/#primaryimage"},"image":{"@id":"https:\/\/zerohorabrasil.com\/ultimas-noticias\/consulta-publica-avalia-inclusao-no-sus-de-remedio-para-hipertensao\/#primaryimage"},"thumbnailUrl":"https:\/\/zerohorabrasil.com\/wp-content\/uploads\/2026\/08\/29326-consulta-publica-avalia-inclusao-no-sus-de-remedio-para-hipertensao.jpg","datePublished":"2026-08-10T13:31:27+00:00","author":{"@id":"https:\/\/zerohorabrasil.com\/#\/schema\/person\/babb8a03cd770e7624473e9dc0bcc401"},"breadcrumb":{"@id":"https:\/\/zerohorabrasil.com\/ultimas-noticias\/consulta-publica-avalia-inclusao-no-sus-de-remedio-para-hipertensao\/#breadcrumb"},"inLanguage":"pt-BR","potentialAction":[{"@type":"ReadAction","target":["https:\/\/zerohorabrasil.com\/ultimas-noticias\/consulta-publica-avalia-inclusao-no-sus-de-remedio-para-hipertensao\/"]}]},{"@type":"ImageObject","inLanguage":"pt-BR","@id":"https:\/\/zerohorabrasil.com\/ultimas-noticias\/consulta-publica-avalia-inclusao-no-sus-de-remedio-para-hipertensao\/#primaryimage","url":"https:\/\/zerohorabrasil.com\/wp-content\/uploads\/2026\/08\/29326-consulta-publica-avalia-inclusao-no-sus-de-remedio-para-hipertensao.jpg","contentUrl":"https:\/\/zerohorabrasil.com\/wp-content\/uploads\/2026\/08\/29326-consulta-publica-avalia-inclusao-no-sus-de-remedio-para-hipertensao.jpg","width":1600,"height":800,"caption":"Consulta p\u00fablica avalia inclus\u00e3o no SUS de rem\u00e9dio para hipertens\u00e3o"},{"@type":"BreadcrumbList","@id":"https:\/\/zerohorabrasil.com\/ultimas-noticias\/consulta-publica-avalia-inclusao-no-sus-de-remedio-para-hipertensao\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"In\u00edcio","item":"https:\/\/zerohorabrasil.com\/"},{"@type":"ListItem","position":2,"name":"Consulta p\u00fablica avalia inclus\u00e3o no SUS de rem\u00e9dio para hipertens\u00e3o"}]},{"@type":"WebSite","@id":"https:\/\/zerohorabrasil.com\/#website","url":"https:\/\/zerohorabrasil.com\/","name":"","description":"Zh Brasil","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/zerohorabrasil.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"pt-BR"},{"@type":"Person","@id":"https:\/\/zerohorabrasil.com\/#\/schema\/person\/babb8a03cd770e7624473e9dc0bcc401","name":"Paula Laboissiere - Reporter da Agencia Brasil","image":{"@type":"ImageObject","inLanguage":"pt-BR","@id":"https:\/\/secure.gravatar.com\/avatar\/be7b690da94cabc2c5adfe3cc496f57cd07f0fce2816487d69375f431356fe96?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/be7b690da94cabc2c5adfe3cc496f57cd07f0fce2816487d69375f431356fe96?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/be7b690da94cabc2c5adfe3cc496f57cd07f0fce2816487d69375f431356fe96?s=96&d=mm&r=g","caption":"Paula Laboissiere - Reporter da Agencia Brasil"},"url":"https:\/\/zerohorabrasil.com\/author\/paula-laboissiere-reporter-da-agencia-brasil-2\/"}]}},"jetpack_sharing_enabled":true,"jetpack-related-posts":[{"id":25669,"url":"https:\/\/zerohorabrasil.com\/saude-e-bem-estar\/sus-inclui-nova-terapia-para-pacientes-adultos-com-leucemia-mieloide\/","url_meta":{"origin":29326,"position":0},"title":"SUS inclui nova terapia para pacientes adultos com leucemia mieloide","author":"Agencia Brasil","date":"15 de junho de 2026","format":false,"excerpt":"O Minist\u00e9rio da Sa\u00fade passar\u00e1 a inserir, no Sistema \u00danico de Sa\u00fade (SUS), o tratamento combinado de venetoclax com azacitidina para pacientes adultos com leucemia mieloide aguda rec\u00e9m-diagnosticada.A combina\u00e7\u00e3o dos medicamentos \u00e9 indicada a pacientes que, por condi\u00e7\u00f5es cl\u00ednicas, n\u00e3o s\u00e3o eleg\u00edveis ao tratamento padr\u00e3o com quimioterapia intensiva, sendo mais\u2026","rel":"","context":"Em &quot;Sa\u00fade e Bem-Estar&quot;","block_context":{"text":"Sa\u00fade e Bem-Estar","link":"https:\/\/zerohorabrasil.com\/informacoes\/saude-e-bem-estar\/"},"img":{"alt_text":"sus-inclui-nova-terapia-para-pacientes-adultos-com-leucemia-mieloide","src":"https:\/\/i0.wp.com\/zerohorabrasil.com\/wp-content\/uploads\/2026\/06\/25669-sus-inclui-nova-terapia-para-pacientes-adultos-com-leucemia-mieloide.jpg?resize=350%2C200&ssl=1","width":350,"height":200,"srcset":"https:\/\/i0.wp.com\/zerohorabrasil.com\/wp-content\/uploads\/2026\/06\/25669-sus-inclui-nova-terapia-para-pacientes-adultos-com-leucemia-mieloide.jpg?resize=350%2C200&ssl=1 1x, https:\/\/i0.wp.com\/zerohorabrasil.com\/wp-content\/uploads\/2026\/06\/25669-sus-inclui-nova-terapia-para-pacientes-adultos-com-leucemia-mieloide.jpg?resize=525%2C300&ssl=1 1.5x, https:\/\/i0.wp.com\/zerohorabrasil.com\/wp-content\/uploads\/2026\/06\/25669-sus-inclui-nova-terapia-para-pacientes-adultos-com-leucemia-mieloide.jpg?resize=700%2C400&ssl=1 2x, https:\/\/i0.wp.com\/zerohorabrasil.com\/wp-content\/uploads\/2026\/06\/25669-sus-inclui-nova-terapia-para-pacientes-adultos-com-leucemia-mieloide.jpg?resize=1050%2C600&ssl=1 3x, https:\/\/i0.wp.com\/zerohorabrasil.com\/wp-content\/uploads\/2026\/06\/25669-sus-inclui-nova-terapia-para-pacientes-adultos-com-leucemia-mieloide.jpg?resize=1400%2C800&ssl=1 4x"},"classes":[]},{"id":7602,"url":"https:\/\/zerohorabrasil.com\/caixa-paga-bolsa-familia-a-beneficiarios-com-nis-de-final-3-3\/","url_meta":{"origin":29326,"position":1},"title":"caixa-paga-bolsa-familia-a-beneficiarios-com-nis-de-final-3","author":"Paula Laboissiere - Reporter da Agencia Brasil","date":"20 de agosto de 2025","format":false,"excerpt":"Caixa paga Bolsa Fam\u00edlia a benefici\u00e1rios com NIS de final 3","rel":"","context":"Post similar","block_context":{"text":"Post similar","link":""},"img":{"alt_text":"caixa-paga-bolsa-familia-a-beneficiarios-com-nis-de-final-3","src":"https:\/\/i0.wp.com\/zerohorabrasil.com\/wp-content\/uploads\/2025\/08\/7601-caixa-paga-bolsa-familia-a-beneficiarios-com-nis-de-final-3.jpg?resize=350%2C200&ssl=1","width":350,"height":200,"srcset":"https:\/\/i0.wp.com\/zerohorabrasil.com\/wp-content\/uploads\/2025\/08\/7601-caixa-paga-bolsa-familia-a-beneficiarios-com-nis-de-final-3.jpg?resize=350%2C200&ssl=1 1x, https:\/\/i0.wp.com\/zerohorabrasil.com\/wp-content\/uploads\/2025\/08\/7601-caixa-paga-bolsa-familia-a-beneficiarios-com-nis-de-final-3.jpg?resize=525%2C300&ssl=1 1.5x, https:\/\/i0.wp.com\/zerohorabrasil.com\/wp-content\/uploads\/2025\/08\/7601-caixa-paga-bolsa-familia-a-beneficiarios-com-nis-de-final-3.jpg?resize=700%2C400&ssl=1 2x, https:\/\/i0.wp.com\/zerohorabrasil.com\/wp-content\/uploads\/2025\/08\/7601-caixa-paga-bolsa-familia-a-beneficiarios-com-nis-de-final-3.jpg?resize=1050%2C600&ssl=1 3x, https:\/\/i0.wp.com\/zerohorabrasil.com\/wp-content\/uploads\/2025\/08\/7601-caixa-paga-bolsa-familia-a-beneficiarios-com-nis-de-final-3.jpg?resize=1400%2C800&ssl=1 4x"},"classes":[]},{"id":26534,"url":"https:\/\/zerohorabrasil.com\/saude-e-bem-estar\/ministerio-da-saude-inicia-projeto-piloto-com-semaglutida-no-sus\/","url_meta":{"origin":29326,"position":2},"title":"Minist\u00e9rio da Sa\u00fade inicia projeto-piloto com semaglutida no SUS","author":"","date":"26 de junho de 2026","format":false,"excerpt":"O Minist\u00e9rio da Sa\u00fade anunciou nesta sexta-feira (26) o in\u00edcio do uso da semaglutida em pacientes atendidos pelo Sistema \u00danico de Sa\u00fade (SUS) em um projeto-piloto no Rio Grande do Sul. Participar\u00e3o do projeto pacientes acompanhados pelo Grupo Hospitalar Concei\u00e7\u00e3o, no Rio Grande do Sul.A semaglutida \u00e9 o princ\u00edpio ativo\u2026","rel":"","context":"Em &quot;Sa\u00fade e Bem-Estar&quot;","block_context":{"text":"Sa\u00fade e Bem-Estar","link":"https:\/\/zerohorabrasil.com\/informacoes\/saude-e-bem-estar\/"},"img":{"alt_text":"ministerio-da-saude-inicia-projeto-piloto-com-semaglutida-no-sus","src":"https:\/\/i0.wp.com\/zerohorabrasil.com\/wp-content\/uploads\/2026\/06\/26534-ministerio-da-saude-inicia-projeto-piloto-com-semaglutida-no-sus.jpg?resize=350%2C200&ssl=1","width":350,"height":200,"srcset":"https:\/\/i0.wp.com\/zerohorabrasil.com\/wp-content\/uploads\/2026\/06\/26534-ministerio-da-saude-inicia-projeto-piloto-com-semaglutida-no-sus.jpg?resize=350%2C200&ssl=1 1x, https:\/\/i0.wp.com\/zerohorabrasil.com\/wp-content\/uploads\/2026\/06\/26534-ministerio-da-saude-inicia-projeto-piloto-com-semaglutida-no-sus.jpg?resize=525%2C300&ssl=1 1.5x, https:\/\/i0.wp.com\/zerohorabrasil.com\/wp-content\/uploads\/2026\/06\/26534-ministerio-da-saude-inicia-projeto-piloto-com-semaglutida-no-sus.jpg?resize=700%2C400&ssl=1 2x, https:\/\/i0.wp.com\/zerohorabrasil.com\/wp-content\/uploads\/2026\/06\/26534-ministerio-da-saude-inicia-projeto-piloto-com-semaglutida-no-sus.jpg?resize=1050%2C600&ssl=1 3x, https:\/\/i0.wp.com\/zerohorabrasil.com\/wp-content\/uploads\/2026\/06\/26534-ministerio-da-saude-inicia-projeto-piloto-com-semaglutida-no-sus.jpg?resize=1400%2C800&ssl=1 4x"},"classes":[]},{"id":8088,"url":"https:\/\/zerohorabrasil.com\/saude-e-bem-estar\/prefeitura-de-sao-paulo-vai-ampliar-oferta-de-canabidiol-pelo-sus\/","url_meta":{"origin":29326,"position":3},"title":"Prefeitura de S\u00e3o Paulo vai ampliar oferta de canabidiol pelo SUS","author":"","date":"26 de agosto de 2025","format":false,"excerpt":"A Secretaria Municipal da Sa\u00fade de S\u00e3o Paulo anunciou nesta segunda-feira (25) que passar\u00e1 a usar medicamentos \u00e0 base de canabidiol, subst\u00e2ncia qu\u00edmica da cannabis, para o tratamento de mais de 30 tipos de doen\u00e7as ou transtornos na rede p\u00fablica.Os pacientes, que anteriormente recorriam \u00e0 via judicial para conseguir o\u2026","rel":"","context":"Em &quot;Sa\u00fade e Bem-Estar&quot;","block_context":{"text":"Sa\u00fade e Bem-Estar","link":"https:\/\/zerohorabrasil.com\/informacoes\/saude-e-bem-estar\/"},"img":{"alt_text":"prefeitura-de-sao-paulo-vai-ampliar-oferta-de-canabidiol-pelo-sus","src":"https:\/\/i0.wp.com\/zerohorabrasil.com\/wp-content\/uploads\/2025\/08\/8088-prefeitura-de-sao-paulo-vai-ampliar-oferta-de-canabidiol-pelo-sus.jpg?resize=350%2C200&ssl=1","width":350,"height":200,"srcset":"https:\/\/i0.wp.com\/zerohorabrasil.com\/wp-content\/uploads\/2025\/08\/8088-prefeitura-de-sao-paulo-vai-ampliar-oferta-de-canabidiol-pelo-sus.jpg?resize=350%2C200&ssl=1 1x, https:\/\/i0.wp.com\/zerohorabrasil.com\/wp-content\/uploads\/2025\/08\/8088-prefeitura-de-sao-paulo-vai-ampliar-oferta-de-canabidiol-pelo-sus.jpg?resize=525%2C300&ssl=1 1.5x, https:\/\/i0.wp.com\/zerohorabrasil.com\/wp-content\/uploads\/2025\/08\/8088-prefeitura-de-sao-paulo-vai-ampliar-oferta-de-canabidiol-pelo-sus.jpg?resize=700%2C400&ssl=1 2x, https:\/\/i0.wp.com\/zerohorabrasil.com\/wp-content\/uploads\/2025\/08\/8088-prefeitura-de-sao-paulo-vai-ampliar-oferta-de-canabidiol-pelo-sus.jpg?resize=1050%2C600&ssl=1 3x, https:\/\/i0.wp.com\/zerohorabrasil.com\/wp-content\/uploads\/2025\/08\/8088-prefeitura-de-sao-paulo-vai-ampliar-oferta-de-canabidiol-pelo-sus.jpg?resize=1400%2C800&ssl=1 4x"},"classes":[]},{"id":10151,"url":"https:\/\/zerohorabrasil.com\/saude-e-bem-estar\/ans-inclui-medicamentos-para-lupus-no-rol-de-coberturas-obrigatorias\/","url_meta":{"origin":29326,"position":4},"title":"ANS inclui medicamentos\u00a0para l\u00fapus no rol de coberturas obrigat\u00f3rias","author":"","date":"20 de setembro de 2025","format":false,"excerpt":"A diretoria colegiada da Ag\u00eancia Nacional de Sa\u00fade Suplementar (ANS) aprovou nesta semana a inclus\u00e3o de dois medicamentos para o tratamento de l\u00fapus no Rol de Procedimentos em Eventos em Sa\u00fade, tornando obrigat\u00f3ria a cobertura desses tratamentos para os benefici\u00e1rios de planos de sa\u00fade.A medida vale apenas para pacientes de\u2026","rel":"","context":"Em &quot;Sa\u00fade e Bem-Estar&quot;","block_context":{"text":"Sa\u00fade e Bem-Estar","link":"https:\/\/zerohorabrasil.com\/informacoes\/saude-e-bem-estar\/"},"img":{"alt_text":"ans-inclui-medicamentos\u00a0para-lupus-no-rol-de-coberturas-obrigatorias","src":"https:\/\/i0.wp.com\/zerohorabrasil.com\/wp-content\/uploads\/2025\/09\/10151-ans-inclui-medicamentos-para-lupus-no-rol-de-coberturas-obrigatorias.png?resize=350%2C200&ssl=1","width":350,"height":200,"srcset":"https:\/\/i0.wp.com\/zerohorabrasil.com\/wp-content\/uploads\/2025\/09\/10151-ans-inclui-medicamentos-para-lupus-no-rol-de-coberturas-obrigatorias.png?resize=350%2C200&ssl=1 1x, https:\/\/i0.wp.com\/zerohorabrasil.com\/wp-content\/uploads\/2025\/09\/10151-ans-inclui-medicamentos-para-lupus-no-rol-de-coberturas-obrigatorias.png?resize=525%2C300&ssl=1 1.5x, https:\/\/i0.wp.com\/zerohorabrasil.com\/wp-content\/uploads\/2025\/09\/10151-ans-inclui-medicamentos-para-lupus-no-rol-de-coberturas-obrigatorias.png?resize=700%2C400&ssl=1 2x, https:\/\/i0.wp.com\/zerohorabrasil.com\/wp-content\/uploads\/2025\/09\/10151-ans-inclui-medicamentos-para-lupus-no-rol-de-coberturas-obrigatorias.png?resize=1050%2C600&ssl=1 3x"},"classes":[]},{"id":30207,"url":"https:\/\/zerohorabrasil.com\/saude-e-bem-estar\/distribuicao-de-medicamentos-para-esclerose-multipla-aumentou\/","url_meta":{"origin":29326,"position":5},"title":"Distribui\u00e7\u00e3o de medicamentos para esclerose m\u00faltipla aumentou","author":"Flavia Albuquerque - Reporter da Agencia Brasil","date":"24 de agosto de 2026","format":false,"excerpt":"Uma an\u00e1lise de dados feita por pesquisadores do Einstein Hospital Israelita revelou que, ap\u00f3s a revis\u00e3o das diretrizes nacionais, a distribui\u00e7\u00e3o pelo Sistema \u00danico de Sa\u00fade (SUS), entre 2019 e 2023,\u00a0de Natalizumabe, medicamento indicado para pacientes com formas mais agressivas de esclerose m\u00faltipla, aumentou 44,5% em todo o pa\u00eds. \u00a0Houve\u2026","rel":"","context":"Em &quot;Sa\u00fade e Bem-Estar&quot;","block_context":{"text":"Sa\u00fade e Bem-Estar","link":"https:\/\/zerohorabrasil.com\/informacoes\/saude-e-bem-estar\/"},"img":{"alt_text":"distribuicao-de-medicamentos-para-esclerose-multipla-aumentou","src":"https:\/\/i0.wp.com\/zerohorabrasil.com\/wp-content\/uploads\/2026\/08\/30207-distribuicao-de-medicamentos-para-esclerose-multipla-aumentou.png?resize=350%2C200&ssl=1","width":350,"height":200,"srcset":"https:\/\/i0.wp.com\/zerohorabrasil.com\/wp-content\/uploads\/2026\/08\/30207-distribuicao-de-medicamentos-para-esclerose-multipla-aumentou.png?resize=350%2C200&ssl=1 1x, https:\/\/i0.wp.com\/zerohorabrasil.com\/wp-content\/uploads\/2026\/08\/30207-distribuicao-de-medicamentos-para-esclerose-multipla-aumentou.png?resize=525%2C300&ssl=1 1.5x, https:\/\/i0.wp.com\/zerohorabrasil.com\/wp-content\/uploads\/2026\/08\/30207-distribuicao-de-medicamentos-para-esclerose-multipla-aumentou.png?resize=700%2C400&ssl=1 2x, https:\/\/i0.wp.com\/zerohorabrasil.com\/wp-content\/uploads\/2026\/08\/30207-distribuicao-de-medicamentos-para-esclerose-multipla-aumentou.png?resize=1050%2C600&ssl=1 3x, https:\/\/i0.wp.com\/zerohorabrasil.com\/wp-content\/uploads\/2026\/08\/30207-distribuicao-de-medicamentos-para-esclerose-multipla-aumentou.png?resize=1400%2C800&ssl=1 4x"},"classes":[]}],"jetpack_featured_media_url":"https:\/\/zerohorabrasil.com\/wp-content\/uploads\/2026\/08\/29326-consulta-publica-avalia-inclusao-no-sus-de-remedio-para-hipertensao.jpg","_links":{"self":[{"href":"https:\/\/zerohorabrasil.com\/wp-json\/wp\/v2\/posts\/29326","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/zerohorabrasil.com\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/zerohorabrasil.com\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/zerohorabrasil.com\/wp-json\/wp\/v2\/users\/340"}],"replies":[{"embeddable":true,"href":"https:\/\/zerohorabrasil.com\/wp-json\/wp\/v2\/comments?post=29326"}],"version-history":[{"count":0,"href":"https:\/\/zerohorabrasil.com\/wp-json\/wp\/v2\/posts\/29326\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/zerohorabrasil.com\/wp-json\/wp\/v2\/media\/29327"}],"wp:attachment":[{"href":"https:\/\/zerohorabrasil.com\/wp-json\/wp\/v2\/media?parent=29326"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/zerohorabrasil.com\/wp-json\/wp\/v2\/categories?post=29326"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/zerohorabrasil.com\/wp-json\/wp\/v2\/tags?post=29326"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}